Theravance Biopharma Inc (TBPH) — Free Cash Flow Generation Index

Latest as of June 2025: 1.00x

Theravance Biopharma Inc (TBPH) has a Free Cash Flow Generation Index of 1.00x as of June 2025. Free cash flow of $208.04 Million represents 1% of operating cash flow ($208.07 Million). See TBPH net working capital ratio to evaluate short-term liquidity relative to the company's equity base.

FCF Generation Index

1.00x

Free Cash Flow / Operating CF

Free Cash Flow

$208.04 Million

USD

Operating Cash Flow

$208.07 Million

USD

Capital Expenditures

$34.00K

USD

Theravance Biopharma Inc Free Cash Flow Generation Index (2025–2025)

Historical FCF Generation Index trend for Theravance Biopharma Inc across 1 annual periods. Explore how well can Theravance Biopharma Inc service its debt to assess how comfortably operating cash covers total debt obligations.

Annual Free Cash Flow Generation for Theravance Biopharma Inc (2025–2025)

Year-by-year Free Cash Flow Generation Index for Theravance Biopharma Inc. For the full company profile including market capitalisation, see how much is Theravance Biopharma Inc worth.

Year	FCG Index	Free Cash Flow (USD)	Operating CF	Capital Expenditures	YoY Change
2025	1.00x	$238.50 Million	$238.54 Million	$42.00K	—

FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).